|

GPC2 CAR T cells Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: GPC2-directed CAR T cells

Pipeline

Phase 1: 2

Top Sponsors

  • Stephan Grupp MD PhD1
  • Stanford University1

Indications

  • Cancer2
  • Metastatic Retinoblastoma1
  • FOXR2-activated1
  • CNS Neuroblastoma1
  • Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS1

Palo Alto, California1 trial

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Lucile Packard Children's Hospital Stanford

Phase 1

Philadelphia, Pennsylvania1 trial

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

Children's Hospital of Philadelphia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.